SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is surging following blowout quarterly results, featuring a massive beat on top and bottom-line figures driven by exceptional growth in U.S. commercial revenue. The community is actively celebrating the company's raised forward guidance, with bulls heavily targeting short sellers and speculating on a potential sustained rally toward higher price levels.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc is trending as investors weigh strong expectations for upcoming earnings against persistent concerns over the company's long-term growth and leadership, with the community actively debating whether upcoming AI and AR initiatives can justify a turnaround. While bulls highlight improving advertising momentum and potential upside from AI-powered ad tools, bears remain skeptical of the stock's performance, citing ongoing management criticism and a history of volatility.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the announcement of a debt-for-equity exchange involving a $1.4 billion debt reduction, a move sparking heated debate among investors regarding the balance between improved financial flexibility and immediate share dilution. While some community members view the move as a strategic cleanup of the balance sheet in preparation for potential acquisitions, others are expressing frustration over the persistent share price pressure and questioning the leadership's long-term capital allocation strategy.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the official UAE approval of ANKTIVA for bladder and lung cancer indications, which is being viewed by the community as a significant step in the company's global expansion. Investors are actively discussing the potential for a larger, imminent partnership announcement and are closely watching upcoming quarterly earnings as a critical catalyst to pressure the stock's high short interest.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies is experiencing a surge in trading activity following a stellar earnings report that beat revenue expectations, bolstered by a record backlog and significant new government contracts in the defense and space infrastructure sectors. The community is actively discussing the stock's growth potential versus its ongoing path to profitability, with many investors closely monitoring whether the company can successfully scale its operations to meet this accelerating demand.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is at the center of intense market speculation after an FDA advisory committee voted 10-3 in favor of the efficacy of its melanoma treatment, RP1, despite previous regulatory setbacks and critical briefing documents. Community sentiment is deeply polarized, with investors weighing the potential for a massive short squeeze and successful regulatory pivot against concerns over trial design, financial dilution risks, and the possibility of a third complete response letter.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing heightened activity as the community anticipates the upcoming 80th event data from the Phase 3 REGAL trial, with investors actively debating potential buyout rumors and clinical milestones. The stock is drawing intense focus from both long-term bulls and short-sellers who are closely tracking institutional ownership shifts and market structure signals, such as limited option expirations, while waiting for a major catalyst.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is surging following the announcement of a five-year, multi-exabyte storage agreement valued at $335 million with CoreWeave, which has significantly bolstered investor sentiment around its role in AI infrastructure. The community is actively debating whether this deal signals a long-term re-rating for the stock or if it sets the stage for a potential equity offering to fund growth.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is at the center of investor focus as the market awaits its upcoming quarterly earnings report, with sentiment currently driven by a mix of analyst upgrades and debates over the company's long-term profitability goals. Community discussion is intensely focused on the potential impact of new AI-integrated features, recent subscription price adjustments, and whether the stock's recent price action signals a sustainable breakout or a looming pullback ahead of the earnings release.

Sterling Infrastructure, Inc. engages in the provision of construction solutions. It operates through the following segments: Transportation Solutions, E-Infrastructure Solutions, and Building Solutions. The Transportation Solutions segment provides infrastructure and rehabilitation services for highways, roads, bridges, airports, ports, light rail systems, water and wastewater facilities, and storm drainage systems. The E-Infrastructure Solutions segment develops advanced, large-scale site development systems and services for data centers, e-commerce distribution centers, warehousing facilities, transportation projects, energy infrastructure, and other specialized developments. The Building Solutions segment provides residential and commercial concrete foundation services for single-family and multi-family homes, as well as parking structures, elevated slabs, and other concrete construction projects. The company was founded in 1955 and is headquartered in The Woodlands, TX.

Sterling Infrastructure Inc

Sterling Construction Company, Inc.

Sterling Infrastructure is seeing significant community discussion and market activity as investors weigh its role as a key "picks and shovels" play in the AI data center buildout against recent stock price volatility and broader sector sell-offs. While many community members remain bullish on the company's strong fundamentals and record order backlog, others are actively debating whether its recent price action is driven by institutional manipulation or a rational revaluation amid cooling market sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?

Equity

A potential AstraZeneca-Bristol Myers deal worth $400 billion would create one of the world’s largest drugmakers and combine major cancer franchises.

Nasdaq, S&P 500 Futures Rise: Microsoft Lifts AI Mood, Meta Sinks, Investors Brace For Apple, Amazon And PCE – Why MU, IBRX, CAPR, SBUX Are In Focus

Data on Stocktwits showed that retail sentiment remains ‘bearish’ on SPY and QQQ. 



Dow, S&P 500, Nasdaq Futures Rise As Investors Shrug Off Fed Hold, Big Tech Earnings: IBRX, MSFT, SOFI, META In Focus

The Federal Reserve held benchmark interest rates steady for a fifth consecutive session. 

IBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease 

The UAE becomes Anktiva’s fifth regulatory jurisdiction, expanding its footprint to 34 countries and boosting ImmunityBio’s global push.

ImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small Cell Lung Cancer

ImmunityBio, Inc. (NASDAQ: IBRX), a vertically integrated commercial-stage biotechnology company, today announced that the Emirates Drug Establishment (EDE) of the United Arab Emirates (UAE) has granted Marketing Authorization for ANKTIVA (nogapendekin alfa inbakicept) across two indications. The...

IBRX Stock Extends 5-Day Losing Streak — Retail Traders Pin Hopes On ‘Incredibly Strong’ Anktiva Sales And Earnings Beat

Investors are also watching for partnership or buyout catalysts as ImmunityBio expands Anktiva internationally and builds its global NK-cell platform.

IBRX Stock Rises Overnight: Retail Traders Hunt For Global Expansion Clues Ahead Of Biotech Conference

Weekend chatter focused on ImmunityBio’s quiet July, with some bulls calling the silence the “quiet before the kraken.”

SLS, IBRX Rise Overnight: Retail Bets On Big Pharma Buyouts As J&J Chases No. 1 Oncology Spot

J&J’s fast-growing Inlexzo bladder-cancer franchise could make IBRX either strategically attractive or a direct rival.

IBRX Stock Climbs Premarket Despite Investor Stake Cut — Retail Sees ‘Imminent’ Global Rollout Catalyst

Sheets Smith Wealth Management cut its IBRX stake by 7.2% to 512,572 shares.

Can IBRX Stock Keep Its Pulse? Institutional Investors Buy In, Retail Hopes For Big Q2 Surprise

Retail traders are watching to see whether ImmunityBio could announce preliminary Q2 revenue, with some speculating that demand for Anktiva could drive sales above $55 million.

Bullish Sentiment

$SLS

$ONDS

$IBRX

$PYPL

Which of these trending stocks are you most bullish on right now - $SLS, $ONDS, $IBRX, or $PYPL?

Stocktwits

Ondas Inc

PayPal Holdings Inc

Which of these trending stocks are you most bullish on right now - 

Stocktwits Polls

Investors are closely watching for Q2 revenue reports and potential guidance updates amid confusion regarding exact release dates.

Optimism surrounds the international adoption of Anktiva following recent regulatory approvals in the UAE and potential expansion into other regions.

Retail investors frequently debate high short interest, accusing hedge funds of manipulation while remaining committed to long-term gains.

Hopes for future FDA approvals in bladder cancer and other indications drive speculation about massive total addressable market potential.

Feed

News

Sentiment

Earnings

Fundamentals

Info

IBRXImmunityBio Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest IBRX News